Goran Kungulovski, PhD
Goran Kungulovski, PhD
Past: IBC, Stuttgart University; Current: Bioengineering Doo, and Zan Mitrev Clinic
Verified email at zmc.mk - Homepage
Title
Cited by
Cited by
Year
Efficient targeted DNA methylation with chimeric dCas9–Dnmt3a–Dnmt3L methyltransferase
P Stepper, G Kungulovski, RZ Jurkowska, T Chandra, F Krueger, ...
Nucleic acids research 45 (4), 1703-1713, 2017
1582017
Epigenome editing: state of the art, concepts, and perspectives
G Kungulovski, A Jeltsch
Trends in Genetics 32 (2), 101-113, 2016
1412016
Targeted epigenome editing of an endogenous locus with chromatin modifiers is not stably maintained
G Kungulovski, S Nunna, M Thomas, UM Zanger, R Reinhardt, A Jeltsch
Epigenetics & chromatin 8 (1), 1-11, 2015
772015
Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails
I Bock, S Kudithipudi, R Tamas, G Kungulovski, A Dhayalan, A Jeltsch
BMC biochemistry 12 (1), 1-12, 2011
672011
Application of histone modification-specific interaction domains as an alternative to antibodies
G Kungulovski, I Kycia, R Tamas, RZ Jurkowska, S Kudithipudi, C Henry, ...
Genome research 24 (11), 1842-1853, 2014
402014
H3K14ac is linked to methylation of H3K9 by the triple Tudor domain of SETDB1
RZ Jurkowska, S Qin, G Kungulovski, W Tempel, Y Liu, P Bashtrykov, ...
Nature communications 8 (1), 1-13, 2017
392017
The Tudor domain of the PHD finger protein 1 is a dual reader of lysine trimethylation at lysine 36 of histone H3 and lysine 27 of histone variant H3t
I Kycia, S Kudithipudi, R Tamas, G Kungulovski, A Dhayalan, A Jeltsch
Journal of molecular biology 426 (8), 1651-1660, 2014
202014
Application of dual reading domains as novel reagents in chromatin biology reveals a new H3K9me3 and H3K36me2/3 bivalent chromatin state
R Mauser, G Kungulovski, C Keup, R Reinhardt, A Jeltsch
Epigenetics & chromatin 10 (1), 1-19, 2017
132017
Correction of aberrant imprinting by allele‐specific epigenome editing
P Bashtrykov, G Kungulovski, A Jeltsch
Clinical Pharmacology & Therapeutics 99 (5), 482-484, 2016
122016
Application of recombinant TAF3 PHD domain instead of anti-H3K4me3 antibody
G Kungulovski, R Mauser, R Reinhardt, A Jeltsch
Epigenetics & chromatin 9 (1), 1-10, 2016
92016
Affinity reagents for studying histone modifications & guidelines for their quality control
G Kungulovski, R Mauser, A Jeltsch
Epigenomics 7 (7), 1185-1196, 2015
82015
Quality of histone modification antibodies undermines chromatin biology research
G Kungulovski, A Jeltsch
F1000Research 4, 2015
72015
Application of mixed peptide arrays to study combinatorial readout of chromatin modifications
R Mauser, G Kungulovski, D Meral, D Maisch, A Jeltsch
Biochimie 146, 14-19, 2018
52018
Specificity analysis of histone modification-specific antibodies or reading domains on histone peptide arrays
G Kungulovski, I Kycia, R Mauser, A Jeltsch
Peptide Antibodies, 275-284, 2015
52015
Trio clinical exome sequencing in a patient with multicentric carpotarsal osteolysis syndrome: first case report in the Balkans
A Stajkovska, S Mehandziska, M Stavrevska, K Jakovleva, N Nikchevska, ...
Frontiers in genetics 9, 113, 2018
32018
A Pediatric Case of Glioblastoma Multiforme Associated With a Novel Germline p. His112CysfsTer9 Mutation in the MLH1 Gene Accompanied by a p. Arg283Cys Mutation in the TP53 …
A Stajkovska, S Mehandziska, R Rosalia, M Stavrevska, M Janevska, ...
Frontiers in genetics 10, 952, 2019
12019
Genome-wide investigation of the dynamic changes of epigenome modifications after global DNA methylation editing
J Broche, G Kungulovski, P Bashtrykov, P Rathert, A Jeltsch
Nucleic acids research 49 (1), 158-176, 2021
2021
Isolation of nucleosomes having multiple-modified histone protein octamers
A Jeltsch, G Kungulovski, R Mauser
US Patent 10,711,045, 2020
2020
Workflow for the Implementation of Precision Genomics in Healthcare
S Mehandziska, A Stajkovska, M Stavrevska, K Jakovleva, M Janevska, ...
Frontiers in Genetics 11, 619, 2020
2020
Genetic aberrations in chromatin factors are pervasive, mutually exclusive, associated with a high mutational burden and improved response to checkpoint immunotherapy in cancer
M Markovska, R Rosalia, S Aleksandra, M Sanja, M Janevska, ...
bioRxiv, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20